ACE and neoplasm: According to immunohistochemical staining analyses of the original tumor, 38 of 56 patients (67.9%) showed positive staining for conventional DCP (MU-3), whereas 45 of 56 patients (80.4%) showed positive staining for NX-DCP (P-16) (Table 2).